Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272

February 16, 2024
30
 MIN
Other
Apple Podcast Icon - Radio Webflow TemplateSpotify Icon- Radio Webflow TemplateGoogle Podcast Icon - Radio Webflow TemplateAmazon MusicSoundCloud Icon - Radio Webflow Template
Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
Other
February 16, 2024
30
 MIN

Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272

In this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in...

Apple Podcast Icon - Radio Webflow TemplateSpotify Icon- Radio Webflow TemplateGoogle Podcast Icon - Radio Webflow TemplateSoundCloud Icon - Radio Webflow TemplateAmazon Music

Let us know if you enjoyed this episodeIn this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in DNA sequencing and genotyping for mice. Despite their initial unfamiliarity with the technical details, they recognize the company's significant role in pharmaceutical research. They are impressed by its financial performance, noting substantial growth in revenue and EBITDA, along with high margins. The conversation also...

Episode Transcript